Related Experiment Video
Updated: Apr 27, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
Published on: July 17, 2020
Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
Shaowen Jin1, Kaimei Wang, Kang Xu
1Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Abstract:
Our SNP-Chip data demonstrated 7/60 (12%) hepatocellular carcinoma (HCC) patients had PRL-1 copy number amplification. However, its biological functions and signaling pathways in HCC are deficient. Here, we investigated its oncogenic function and prognostic significance in HCC. PRL-1 protein levels were examined in 167 HCC samples by immunohistochemisty (IHC). The relationship of PRL-1 expression and clinicopathological features was assessed by correlation, Kaplan-Meier and Cox regression analyses. The oncogenic function of PRL-1 in HCC cells and its underlying mechanism were investigated by ectopic overexpression and knockdown model. PRL-1 levels in primary HCC and metastatic intravascular cancer thrombus were also determined by IHC. PRL-1 levels were frequently elevated in HCC tissues (81%), and elevated expression of PRL-1 was significantly associated with more aggressive phenotype and poorer prognosis in HCC patients (p<0.05). Ectopic overexpression of PRL-1 markedly enhanced HCC cells migration and invasion. Furthermore, the oncogenic functions of PRL-1 were mediated by PI3K/AKT/GSK3β signaling pathway through inhibiting E-cadherin expression. Finally, PRL-1 protein levels in metastatic cancer thrombus were higher than that in primary HCC tissues (p<0.05). These data highlight the oncogenic function of PRL-1 in HCC invasion and metastasis implicating PRL-1 as a potential prognostic marker as well as therapeutic target in HCC.
Insights
Elevated PRL-1 protein expression is common in hepatocellular carcinoma (HCC), promoting cancer cell invasion and metastasis. This suggests PRL-1 is a potential prognostic marker and therapeutic target for HCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Limited understanding of the biological functions and signaling pathways of PRL-1 in hepatocellular carcinoma (HCC).
- Previous SNP-Chip data indicated PRL-1 copy number amplification in a subset of HCC patients.
Purpose of the Study:
- To investigate the oncogenic function and prognostic significance of PRL-1 in HCC.
- To elucidate the underlying molecular mechanisms of PRL-1's role in HCC progression.
Main Methods:
- Immunohistochemistry (IHC) to assess PRL-1 protein levels in 167 HCC samples and metastatic thrombi.
- Correlation, Kaplan-Meier, and Cox regression analyses to evaluate the association between PRL-1 expression and clinicopathological features.
- In vitro cell models (overexpression and knockdown) to study PRL-1's functional impact on HCC cell migration and invasion.
- Investigation of signaling pathways, including PI3K/AKT/GSK3β, and E-cadherin expression.
Main Results:
- PRL-1 was frequently elevated in HCC tissues (81%) and associated with aggressive phenotypes and poorer prognosis.
- Overexpression of PRL-1 significantly enhanced HCC cell migration and invasion.
- PRL-1's oncogenic functions were mediated by the PI3K/AKT/GSK3β pathway via inhibition of E-cadherin.
- PRL-1 levels were higher in metastatic cancer thrombi compared to primary HCC tissues.
Conclusions:
- PRL-1 exhibits significant oncogenic functions in HCC, particularly in invasion and metastasis.
- Elevated PRL-1 expression serves as a potential prognostic marker for HCC.
- PRL-1 represents a promising therapeutic target for HCC treatment.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

